Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway

Retraction of ‘Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway’ by Jun-Feng Huo et al., RSC Adv., 2019, 9, 28775–28782, DOI: 10.1039/C9RA05572J.

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694638/
https://www.ncbi.nlm.nih.gov/pubmed/35427023
http://dx.doi.org/10.1039/d1ra90038b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694638/
https://www.ncbi.nlm.nih.gov/pubmed/35427023
http://dx.doi.org/10.1039/d1ra90038b

Ejemplares similares